US Stock MarketDetailed Quotes

SWTX SpringWorks Therapeutics

Watchlist
  • 46.300
  • +0.060+0.13%
Close Apr 30 16:00 ET
  • 46.300
  • 0.0000.00%
Post 18:25 ET
3.47BMarket Cap-13.30P/E (TTM)

SpringWorks Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
3,417.33%191.59M
1,029.96%61.55M
49.3M
59.73M
21.01M
5.45M
5.45M
0
0
0
Operating revenue
3,058.47%172.04M
1,029.96%61.55M
--49.3M
--40.19M
--21.01M
--5.45M
--5.45M
--0
--0
--0
Cost of revenue
2,873.93%12.55M
1,216.11%5.55M
3.34M
2.45M
1.2M
422K
422K
0
0
0
Gross profit
3,462.97%179.04M
1,014.33%56M
45.96M
57.28M
19.8M
5.03M
5.03M
0
0
0
Operating expense
31.36%457.17M
32.71%137.34M
23.69%103.9M
23.35%102.2M
46.38%113.74M
24.00%348.04M
31.91%103.49M
17.09%84M
20.06%82.85M
26.40%77.7M
Selling and administrative expenses
29.92%256.65M
28.85%77.1M
32.34%61.6M
23.08%57.84M
36.08%60.11M
46.82%197.55M
47.65%59.84M
30.48%46.55M
51.66%46.99M
61.42%44.18M
-General and administrative expense
29.92%256.65M
28.85%77.1M
32.34%61.6M
23.08%57.84M
36.08%60.11M
46.82%197.55M
47.65%59.84M
30.48%46.55M
51.66%46.99M
61.42%44.18M
Research and development costs
33.25%200.52M
38.00%60.24M
12.93%42.3M
23.72%44.36M
59.95%53.62M
2.99%150.49M
15.09%43.65M
3.84%37.45M
-5.70%35.86M
-1.70%33.52M
Operating profit
18.92%-278.13M
17.39%-81.34M
31.03%-57.94M
45.78%-44.92M
-20.89%-93.93M
-22.21%-343.01M
-25.50%-98.46M
-17.09%-84M
-20.06%-82.85M
-26.40%-77.7M
Net non-operating interest income expense
13.30%26M
-9.05%5.44M
11.28%6.22M
16.30%6.78M
36.24%7.57M
273.30%22.95M
28.10%5.98M
512.50%5.59M
1,466.67%5.83M
2,706.57%5.56M
Non-operating interest income
13.30%26M
-9.05%5.44M
11.28%6.22M
16.30%6.78M
36.24%7.57M
273.30%22.95M
28.10%5.98M
512.50%5.59M
1,466.67%5.83M
2,706.57%5.56M
Other net income (expense)
-19.09%-6M
24.25%-1.39M
-76.66%-1.81M
-97.11%-1.78M
19.80%-1.03M
-74.33%-5.04M
-371.72%-1.84M
34.36%-1.02M
-119.22%-901K
-141.13%-1.28M
Earnings from equity interest
-19.09%-6M
24.25%-1.39M
-76.66%-1.81M
-97.11%-1.78M
19.80%-1.03M
-74.33%-5.04M
-169.85%-1.84M
31.09%-1.02M
-132.82%-901K
-279.23%-1.28M
Income before tax
20.60%-258.13M
18.05%-77.3M
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
Income tax
Net income
20.60%-258.13M
18.05%-77.3M
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
Net income continuous Operations
20.60%-258.13M
18.05%-77.3M
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
Minority interest income
Net income attributable to the parent company
20.60%-258.13M
18.05%-77.3M
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.60%-258.13M
18.05%-77.3M
32.61%-53.53M
48.77%-39.92M
-19.02%-87.39M
-17.19%-325.1M
-27.16%-94.32M
-9.74%-79.44M
-12.85%-77.93M
-18.80%-73.42M
Basic earnings per share
32.43%-3.48
28.28%-1.04
43.31%-0.72
56.80%-0.54
0.00%-1.18
1.15%-5.15
-23.93%-1.45
7.30%-1.27
11.35%-1.25
6.35%-1.18
Diluted earnings per share
32.43%-3.48
28.28%-1.04
43.31%-0.72
56.80%-0.54
0.00%-1.18
1.15%-5.15
-23.93%-1.45
7.30%-1.27
11.35%-1.25
6.35%-1.18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 3,417.33%191.59M1,029.96%61.55M49.3M59.73M21.01M5.45M5.45M000
Operating revenue 3,058.47%172.04M1,029.96%61.55M--49.3M--40.19M--21.01M--5.45M--5.45M--0--0--0
Cost of revenue 2,873.93%12.55M1,216.11%5.55M3.34M2.45M1.2M422K422K000
Gross profit 3,462.97%179.04M1,014.33%56M45.96M57.28M19.8M5.03M5.03M000
Operating expense 31.36%457.17M32.71%137.34M23.69%103.9M23.35%102.2M46.38%113.74M24.00%348.04M31.91%103.49M17.09%84M20.06%82.85M26.40%77.7M
Selling and administrative expenses 29.92%256.65M28.85%77.1M32.34%61.6M23.08%57.84M36.08%60.11M46.82%197.55M47.65%59.84M30.48%46.55M51.66%46.99M61.42%44.18M
-General and administrative expense 29.92%256.65M28.85%77.1M32.34%61.6M23.08%57.84M36.08%60.11M46.82%197.55M47.65%59.84M30.48%46.55M51.66%46.99M61.42%44.18M
Research and development costs 33.25%200.52M38.00%60.24M12.93%42.3M23.72%44.36M59.95%53.62M2.99%150.49M15.09%43.65M3.84%37.45M-5.70%35.86M-1.70%33.52M
Operating profit 18.92%-278.13M17.39%-81.34M31.03%-57.94M45.78%-44.92M-20.89%-93.93M-22.21%-343.01M-25.50%-98.46M-17.09%-84M-20.06%-82.85M-26.40%-77.7M
Net non-operating interest income expense 13.30%26M-9.05%5.44M11.28%6.22M16.30%6.78M36.24%7.57M273.30%22.95M28.10%5.98M512.50%5.59M1,466.67%5.83M2,706.57%5.56M
Non-operating interest income 13.30%26M-9.05%5.44M11.28%6.22M16.30%6.78M36.24%7.57M273.30%22.95M28.10%5.98M512.50%5.59M1,466.67%5.83M2,706.57%5.56M
Other net income (expense) -19.09%-6M24.25%-1.39M-76.66%-1.81M-97.11%-1.78M19.80%-1.03M-74.33%-5.04M-371.72%-1.84M34.36%-1.02M-119.22%-901K-141.13%-1.28M
Earnings from equity interest -19.09%-6M24.25%-1.39M-76.66%-1.81M-97.11%-1.78M19.80%-1.03M-74.33%-5.04M-169.85%-1.84M31.09%-1.02M-132.82%-901K-279.23%-1.28M
Income before tax 20.60%-258.13M18.05%-77.3M32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M
Income tax
Net income 20.60%-258.13M18.05%-77.3M32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M
Net income continuous Operations 20.60%-258.13M18.05%-77.3M32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M
Minority interest income
Net income attributable to the parent company 20.60%-258.13M18.05%-77.3M32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.60%-258.13M18.05%-77.3M32.61%-53.53M48.77%-39.92M-19.02%-87.39M-17.19%-325.1M-27.16%-94.32M-9.74%-79.44M-12.85%-77.93M-18.80%-73.42M
Basic earnings per share 32.43%-3.4828.28%-1.0443.31%-0.7256.80%-0.540.00%-1.181.15%-5.15-23.93%-1.457.30%-1.2711.35%-1.256.35%-1.18
Diluted earnings per share 32.43%-3.4828.28%-1.0443.31%-0.7256.80%-0.540.00%-1.181.15%-5.15-23.93%-1.457.30%-1.2711.35%-1.256.35%-1.18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.